Additionally, the IGF-I/IGF-IR signalling pathway negatively correlates with BRCA1 abundance in breast and prostate cancer cells [21, 22], suggesting an interplay between BRCA1 and IGF-I/IGF-IR signalling. The gene discussed is IGF1R; the disease is Familial prostate cancer.